Aurone Mannich base derivatives as promising multifunctional agents with acetylcholinesterase inhibition, anti-β-amyloid aggragation and neuroprotective properties for the treatment of Alzheimer's disease

Eur J Med Chem. 2017 Jan 27:126:762-775. doi: 10.1016/j.ejmech.2016.12.009. Epub 2016 Dec 5.

Abstract

A series of aurone Mannich base derivatives were designed, synthesized and evaluated as multifunctional agents for the treatment of Alzheimer's disease. In vitro assays demonstrated that most of the derivatives were selective AChE inhibitors with good multifunctional properties. Among them, compound 7d exhibited outstanding inhibitory activity for RatAChE, EeAChE and HuAChE (IC50 = 0.00878 ± 0.0002 μM, 0.0212 ± 0.006 μM and 0.0371 ± 0.004 μM, respectively). Moreover, 7d displayed high antioxidant activity and could confer significant neuroprotective effect against H2O2-induced PC-12 cell injury. In addition, 7d also showed biometal chelating abilities, good self- and Cu2+-induced Aβ1-42 aggregation inhibitory potency and high BBB permeability. These multifunctional properties highlight 7d as promising candidate for further studies directed to the development of novel drugs against AD.

Keywords: Acetylcholinesterase inhibitors; Alzheimer's disease; Aurone Mannich base derivatives; Aβ aggregation inhibitors; Multifunctional agents.

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Amyloid beta-Peptides / antagonists & inhibitors
  • Amyloid beta-Peptides / metabolism
  • Animals
  • Blood-Brain Barrier / drug effects
  • Cholinesterase Inhibitors / chemical synthesis
  • Cholinesterase Inhibitors / pharmacology
  • Drug Design
  • Electrophorus
  • Humans
  • Mannich Bases / chemical synthesis*
  • Mannich Bases / pharmacology
  • Neuroprotective Agents / chemical synthesis
  • Neuroprotective Agents / pharmacology
  • PC12 Cells
  • Rats

Substances

  • Amyloid beta-Peptides
  • Cholinesterase Inhibitors
  • Mannich Bases
  • Neuroprotective Agents